Live Quote · NASDAQNXTCHealthcare· Biotechnology

NextCure, Inc.

$6.45▼ 4.87%($-0.33)
MKT CAP $29.53MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
56/100
▌ Mixed
70
Valuation
20
Profitability
55
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NXTC research report →

Analyst Price Target
$20.00+210.1% vs. today

Range $20 – $20

Analyst RatingBuy
11 Buy1 Hold1 Sell

Price Chart

-27.56% · this period
$14.27$7.93$1.60Nov 19May 22Nov 19
52-Week Range35% of range
Low
$1.55
Current
$6.45
High
$15.74